Editas Medicine, Inc.

Editas Medicine, Inc.

IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Solid Tumours, EDIT-201
Discontinued


Sponsors:
Editas Medicine 
IND Enabling
Phase I
Phase II
Phase III
Sickle Cell Disease, SCD, (NCT04853576)
Sponsors:
Editas Medicine, Inc. 
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Leber Congenital Amaurosis, LCA, (NCT03872479)
Sponsors:
Editas Medicine, Inc.
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine